SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001445815-24-000001
Filing Date
2024-01-16
Accepted
2024-01-16 09:53:42
Documents
1
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 5  
1 PRIMARY DOCUMENT primary_doc.xml 5 3086
  Complete submission text file 0001445815-24-000001.txt   4879
Mailing Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494
Business Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494 617-494-1199
BIOXYTRAN, INC (Issuer) CIK: 0001445815 (see all company filings)

IRS No.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 7 RUE ARISTIDE MAILLOL PARIS I0 75015
Business Address
Chen-Walden Hana (Reporting) CIK: 0001907211 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-35027 | Film No.: 24533958